|Funding for:||UK Students|
|Funding amount:||Not Specified|
|Placed On:||19th November 2021|
|Closes:||19th February 2022|
Dr A Cruz-Cabeza
About the Project
This project is being pursued in collaboration with AstraZeneca and the successful applicant will be part of a larger research group supervised by Dr Cruz-Cabeza and Dr Ashwin Rajagopalan. Most pharmaceutical drugs are delivered as tablets. The design of compliant tablets requires of an in depth understanding of how crystalline particles of Active Pharmaceutical Ingredients behave. This project will use a combination of experimentation (with surface analysis techniques and microscopy) and molecular simulations in order to better understand particle properties such as adhesion or sticking issues to name a few. The successful candidate will be expected to learn both experimentation as well as simulation techniques.
Information about the application process and a link to the online application form can be found at https://www.manchester.ac.uk/study/postgraduate-research/admissions/how-to-apply/. Take note of the application checklist and provide the requested documents. When completing the application include the name of the lead supervisor as the potential supervisor.
Applicants should have or expect to achieve at least a 2.1 honours degree in Chemistry, Chemical Engineering, Physics or Pharmacy.
Enquiries about this studentship can be sent to Dr Cruz-Cabeza (email@example.com) as the lead project supervisor. The Admissions team in CEAS can be contacted at firstname.lastname@example.org with any queries you may have regarding the application process.
Equality, diversity and inclusion is fundamental to the success of The University of Manchester, and is at the heart of all of our activities. We know that diversity strengthens our research community, leading to enhanced research creativity, productivity and quality, and societal and economic impact. We actively encourage applicants from diverse career paths and backgrounds and from all sections of the community, regardless of age, disability, ethnicity, gender, gender expression, sexual orientation and transgender status.
We also support applications from those returning from a career break or other roles. We consider offering flexible study arrangements (including part-time: 50%, 60% or 80%, depending on the project/funder).
All appointments are made on merit.
The University of Manchester and our external partners are fully committed to equality, diversity and inclusion
Funding is offered by the Department of Chemical Engineering and Analytical Science. This is a 4 year iCASE studentship (AstraZeneca + EPSRC) that will cover tuition fees at either the Home or International rate and provide a tax-free stipend at the standard UKRI rate for a PhD starting in September 2022. UK students can apply, and other nationalities may also be considered for exceptional candidates.
Type / Role: